최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.30 no.9, 2020년, pp.819 - 825
All living organisms exhibit the characteristics of aging, such as skin wrinkle formation, muscle degeneration, cataracts, and hair graying as the number of aged cells increases over time. Senescence, which is known as a key cause of aging, is directly related to the aging of living organisms becaus...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Baar, M. P., Brandt, R. M., Putavet, D. A., Klein, J. D., Derks, K. W., Bourgeois, B. R., Stryeck, S., Rijksen, Y., van Willigenburg, H. and Feijtel, D. A. 2017. Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell 169, 132-147. e116.
Borra, M. T., Smith, B. C. and Denu, J. M. 2005. Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem. 280, 17187-17195.
Buffard, T. and Ferbeyre, G. 2020. Senolytics Target Senescent Cells and Improve Aging and Age-Related Diseases.63-84. Senolytics in Disease, Ageing and Longevity: Springer.
Chau, M. N., El Touny, L. H., Jagadeesh, S. and Banerjee, P. P. 2007. Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3. Carcinogenesis 28, 2282-2290.
de Jesus, B. B., Schneeberger, K., Vera, E., Tejera, A., Harley, C. B. and Blasco, M. A. 2011. The telomerase activator TA-65 elongates short telomeres and increases health span of adult/ old mice without increasing cancer incidence. Aging Cell 10, 604-621.
Deng, Z., Li, Y., Liu, H., Xiao, S., Li, L., Tian, J., Cheng, C., Zhang, G. and Zhang, F. 2019. The role of sirtuin 1 and its activator, resveratrol in osteoarthritis. Biosci. Rep. 39, BSR 20190189.
Donato, V., Ayala, F. R., Cogliati, S., Bauman, C., Costa, J. G., Lenini, C. and Grau, R. 2017. Bacillus subtilis biofilm extends Caenorhabditis elegans longevity through downregulation of the insulin-like signalling pathway. Nat. Commun. 8, 1-15.
Dow, C. T. and Harley, C. B. 2016. Evaluation of an oral telomerase activator for early age-related macular degeneration-a pilot study. Clin. Ophthalmol. (Auckland, NZ) 10, 243.
Fang, Y., Tang, S. and Li, X. 2019. Sirtuins in metabolic and epigenetic regulation of stem cells. Trends Endocrinol. Metab. 30, 177-188.
Galiniak, S., Aebisher, D. and Bartusik-Aebisher, D. 2019. Health benefits of resveratrol administration. Acta. Biochimica Polonica 66, 13-21.
Guan, Y., Wang, S. R., Huang, X. Z., Xie, Q. H., Xu, Y. Y., Shang, D. and Hao, C. M. 2017. Nicotinamide mononucleotide, an NAD+ precursor, rescues age-associated susceptibility to AKI in a sirtuin 1-dependent manner. J. Am. Soc. Nephrol. 28, 2337-2352.
Guarente, L. 2000. Sir2 links chromatin silencing, metabolism, and aging. Genes Dev. 14, 1021-1026.
Guerrero, A., Guiho, R., Herranz, N., Uren, A., Withers, D. J., Martinez-Barbera, J. P., Tietze, L. F. and Gil, J. 2020. Galactose-modified duocarmycin prodrugs as senolytics. Aging Cell 19, e13133.
Gupta, S. D. and Pan, C. H. 2020. Recent update on discovery and development of Hsp90 inhibitors as senolytic agents. Int. J. Biol. Macromol. 161, 1086-1098.
Hardeland, R. 2019. Aging, melatonin, and the pro-and anti-inflammatory networks. Int. J. Mol. Cell Med. 20, 1223.
Harley, C. B., Liu, W., Flom, P. L. and Raffaele, J. M. 2013. A natural product telomerase activator as part of a health maintenance program: metabolic and cardiovascular response. Rejuvenation Res. 16, 386-395.
Kida, Y. and Goligorsky, M. S. 2016. Sirtuins, cell senescence, and vascular aging. Can. J. Cardiol. 32, 634-641.
Kirkland, J. L., Tchkonia, T., Zhu, Y., Niedernhofer, L. J. and Robbins, P. D. 2017. The clinical potential of senolytic drugs. J. Am. Geriatr. Soc. 65, 2297-2301.
Kiss, T., Nyul-Toth, A., Balasubramanian, P., Tarantini, S., Ahire, C., Yabluchanskiy, A., Csipo, T., Farkas, E., Wren, J. D. and Garman, L. 2020. Nicotinamide mononucleotide (NMN) supplementation promotes neurovascular rejuvenation in aged mice: transcriptional footprint of SIRT1 activation, mitochondrial protection, anti-inflammatory, and anti-apoptotic effects. Geroscience 42, 527-546.
Le Saux, C. J., Davy, P., Brampton, C., Ahuja, S. S., Fauce, S., Shivshankar, P., Nguyen, H., Ramaseshan, M., Tressler, R. and Pirot, Z. 2013. A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis. PLoS One 8, e58423.
Li, H., Wei, C., Zhou, R., Wang, B., Zhang, Y., Shao, C. and Luo, Y. 2019. Mouse models in modeling aging and cancer. Exp. Gerontol. 120, 88-94.
Lin, C., Li, H., Liu, J., Hu, Q., Zhang, S., Zhang, N., Liu, L., Dai, Y., Cao, D. and Li, X. 2020. Arginine hypomethylation-mediated proteasomal degradation of histone H4-an early biomarker of cellular senescence. Cell Death Differ. 27, 2967-2709.
Liu, X., Belmonte, J. C. I., Zhang, W. and Liu, G. H. 2020. A ${\beta}$ -galactosidase kiss of death for senescent cells. Cell Res. 1-2.
Mai, A., Valente, S., Meade, S., Carafa, V., Tardugno, M., Nebbioso, A., Galmozzi, A., Mitro, N., De Fabiani, E. and Altucci, L. 2009. Study of 1, 4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors. J. Med. Chem. 52, 5496-5504.
Mishra, D. K., Prasad, R. and Yadava, P. 2020.Telomeres, Telomerase, and Aging.119-133. Models, Molecules and Mechanisms in Biogerontology: Springer.
Molgora, B., Bateman, R., Sweeney, G., Finger, D., Dimler, T., Effros, R. B. and Valenzuela, H. F. 2013. Functional assessment of pharmacological telomerase activators in human T cells. Cells 2, 57-66.
Morin, G. B. 1997. Telomere control of replicative lifespan. Exp. Gerontol. 32, 375-382.
Park, S. J., Ahmad, F., Um, J. H., Brown, A. L., Xu, X., Kang, H., Ke, H., Feng, X., Ryall, J. and Philp, A. 2017. Specific Sirt1 activator-mediated improvement in glucose homeostasis requires Sirt1-independent activation of AMPK. EBio Medicine 18, 128-138.
Rahnasto-Rilla, M., Tyni, J. and Lahtela-Kakkonen, M. 2020. Sirtuin inhibitors and activators. Chem. Epigenet. 55-92.
Razgonova, M. P., Zakharenko, A. M., Golokhvast, K. S., Thanasoula, M., Sarandi, E., Nikolouzakis, K., Fragkiadaki, P., Tsoukalas, D., Spandidos, D. A. and Tsatsakis, A. 2020. Telomerase and telomeres in aging theory and chronographic aging theory. Mol. Med. Rep. 22, 1679-1694.
Ren, Z., He, H., Zuo, Z., Xu, Z., Wei, Z. and Deng, J. 2019. The role of different SIRT1-mediated signaling pathways in toxic injury. Cell Mol. Biol. Lett. 24, 36.
Shay, J. W. and Wright, W. E. 2000. Hayflick, his limit, and cellular ageing. Nat. Rev. Mol. Cell Biol. 1, 72-76.
Shi, G., Liu, D., Zhou, B., Liu, Y., Hao, B., Yu, S., Wu, L., Wang, M., Song, Z. and Wu, C. 2020. Ginsenoside Rb1 alleviates oxidative low-density lipoprotein-induced vascular endothelium senescence via the SIRT1/Beclin-1/Autophagy Axis. J. Cardiovasc. Pharmacol. 75, 155-167.
Soni, N. O. 2017. SIRT-1 ACTIVATORS-IN DIABETIC NEPHROPATHY.
Sunthonkun, P., Palajai, R., Somboon, P., Suan, C. L., Ungsurangsri, M. and Soontorngun, N. 2019. Life-span extension by pigmented rice bran in the model yeast Saccharomyces cerevisiae. Sci. Rep. 9, 1-16.
Tichon, A., Eitan, E., Kurkalli, B., Braiman, A., Gazit, A., Slavin, S., Beith-Yannai, E. and Priel, E. 2013. Oxidative stress protection by novel telomerase activators in mesenchymal stem cells derived from healthy and diseased individuals. Curr. Mol. Med. 13, 1010-1022.
Tran, D., Bergholz, J., Zhang, H., He, H., Wang, Y., Zhang, Y., Li, Q., Kirkland, J. L. and Xiao, Z. X. 2014. Insulin-like growth factor-1 regulates the SIRT 1-p53 pathway in cellular senescence. Aging Cell 13, 669-678.
Tsoukalas, D., Fragkiadaki, P., Docea, A. O., Alegakis, A. K., Sarandi, E., Thanasoula, M., Spandidos, D. A., Tsatsakis, A., Razgonova, M. P. and Calina, D. 2019. Discovery of potent telomerase activators: Unfolding new therapeutic and anti-aging perspectives. Mol. Med. Rep. 20, 3701-3708.
Valente, S., Mellini, P., Spallotta, F., Carafa, V., Nebbioso, A., Polletta, L., Carnevale, I., Saladini, S., Trisciuoglio, D. and Gabellini, C. 2016. 1, 4-Dihydropyridines active on the SIRT1/AMPK pathway ameliorate skin repair and mitochondrial function and exhibit inhibition of proliferation in cancer cells. J. Med. Chem. 59, 1471-1491.
Wang, Y., He, J., Liao, M., Hu, M., Li, W., Ouyang, H., Wang, X., Ye, T., Zhang, Y. and Ouyang, L. 2019. An overview of Sirtuins as potential therapeutic target: structure, function and modulators. Eur. J. Med. Chem. 161, 48-77.
Wyllie, F. S., Jones, C. J., Skinner, J. W., Haughton, M. F., Wallis, C., Wynford-Thomas, D., Faragher, R. G. and Kipling, D. 2000. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat. Genet. 24, 16-17.
Zhu, Y., Doornebal, E. J., Pirtskhalava, T., Giorgadze, N., Wentworth, M., Fuhrmann-Stroissnigg, H., Niedernhofer, L. J., Robbins, P. D., Tchkonia, T. and Kirkland, J. L. 2017. New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Aging (Albany NY) 9, 955.
Zhu, Y., Liu, X., Ding, X., Wang, F. and Geng, X. 2019. Telomere and its role in the aging pathways: telomere shortening, cell senescence and mitochondria dysfunction. Biogerontology 20, 1-16.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.